retatrutide creator Umbrella Labs Peptide Research Use Only Program Supports High Rigor Multi Receptor Endocrine Signaling, Metabolic Pathway Mapping, And Reproducible Bench Workflows Retatrutide Phase 3 Trials Breakdown

Mounjaro (tirzepatide) is a dual-action medication mimicking both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide)

Your formulation may be customized by your provider during the consultation

We talk about things like: How much protein do you actually need

Common Side Effects Mild nausea (most common, usually improves within a few weeks) Diarrhea or constipation due to slowed digestion Bloating or fullness after meals Mild headaches or fatigue Less Common But Serious Side Effects Pancreatitis (rare) Watch for persistent, severe abdominal pain. Hypoglycemia (rare in non-diabetics) Can occur when combined with insulin therapy. Allergic reactions (very rare) Monitor for rash, swelling, or difficulty breathing